
Chorus Pharmachem Private Limited
Manufactures pharma intermediates and provides pharmaceutical services such as custom synthesis and contract research.
Manufactures pharma intermediates and provides pharmaceutical services such as custom synthesis and contract research.
Chorus Pharmachem Private Limited (CPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 May 2008 and has a history of 16 years and 11 months. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹15.00 Cr. The company has closed loans amounting to ₹3.50 M, as per Ministry of Corporate Affairs (MCA) records.
Himanshu Shah, Sanjaykumar Patel, Giraben Patel, and Three other members serve as directors at the Company.
Vadodara, Gujarat, India
+91-XXXXXXXXXX
U24234GJ2008PTC053845
053845
Private Limited Indian Non-Government Company
08 May 2008
30 Sep 2023
31 Mar 2023
Unlisted
Roc Ahmedabad
Chorus Pharmachem Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Himanshu Shah ![]() | Director | 08-May-2008 | Current |
Sanjaykumar Patel ![]() | Director | 08-May-2008 | Current |
Giraben Patel ![]() | Director | 30-Sep-2013 | Current |
Chetan Patel ![]() | Director | 30-Sep-2013 | Current |
Atulkumar Patel ![]() | Director | 14-Jun-2012 | Current |
Anilkumar Patel ![]() | Director | 30-Sep-2013 | Current |
Chorus Pharmachem Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 50.45% decrease. The company also saw a substantial fall in profitability, with a 103.06% decrease in profit. The company's net worth moved up by a moderate rise of 3.51%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Chorus Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Atulkumar Patel is a mutual person
₹15.00 Cr
₹0.35 Cr
Date | Lender | Amount | Status |
---|---|---|---|
18 Dec 2017 | Axis Bank Limited | ₹7.50 Cr | Open |
16 Dec 2017 | Axis Bank Limited | ₹7.50 Cr | Open |
04 Jan 2012 | Hdfc Bank Limited | ₹3.50 M | Satisfied |
Chorus Pharmachem has a workforce of 20 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Chorus Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chorus Pharmachem's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Chorus Pharmachem Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Chorus Pharmachem Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.
A charge with Axis Bank Limited of Rs. 7.50 Cr registered on 18 Dec 2017 with Charge ID 100145210 was modified on 07 Nov 2022.
A charge with Axis Bank Limited amounted to Rs. 7.50 Cr with Charge ID 100145210 was registered on 18 Dec 2017.
A charge with Axis Bank Limited amounted to Rs. 7.50 Cr with Charge ID 100145213 was registered on 16 Dec 2017.
A charge registered on 04 Jan 2012 via Charge ID 10327641 with Hdfc Bank Limited was fully satisfied on 23 May 2015.
Chorus Pharmachem Private Limited was incorporated on 08 May 2008.
The authorized share capital of Chorus Pharmachem Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 2.00 Cr.
Currently 6 directors are associated with Chorus Pharmachem Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Chorus Pharmachem Private Limited is Plot No. 184-185 Gidc Estate, India, Nandesari, Gujarat, 391340.
The corporate identification number (CIN) of Chorus Pharmachem Private Limited is U24234GJ2008PTC053845 and the company number is 053845 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Chorus Pharmachem Private Limited has fallen by -50.45%.
As Per 2023 financial reports, 20 employees are currently employed by Chorus Pharmachem Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Chorus Pharmachem Private Limited has experienced an upsurge of 3.51%.
As per the financial statements for fiscal Year 2023, The total open charges for Chorus Pharmachem Private Limited amount to ₹ 15.00 Cr.
The most recent Balance Sheet for Chorus Pharmachem Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
MP